Temat: "ESSENTIAL hypertension"

Skocz do pozycji: 1 1.

Tytuł :: The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}.
Autorzy :: Xu M; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Zhang X; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Ye R; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Liu X; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Sun L; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Jia S; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Zhang Z; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Li X; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Wang Z; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Liao H; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Shi R; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Liu K; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Wang S; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Meng Q; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China. .
Chen X; Cardiology Department, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China. .; Pokaż więcej
Źródło :: Trials [Trials] 2023 Nov 28; Vol. 24 (1), pp. 770. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji :: Clinical Trial Protocol; Journal Article
MeSH Terms :: Amlodipine*/administration & dosage
Antihypertensive Agents*/administration & dosage
Essential Hypertension*/drug therapy
Humans ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Circadian Rhythm ; East Asian People ; Multicenter Studies as Topic ; Prospective Studies ; Randomized Controlled Trials as Topic
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 2 2.

Tytuł :: Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study.
Autorzy :: Zhang J; Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang W; Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yan J; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, Guangdong, China.
Ge Q; Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lu XH; Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen SX; Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu WJ; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, Guangdong, China.
Li Y; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, Guangdong, China.
Li JF; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, Guangdong, China.
He SY; Shenzhen Salubris Pharmaceuticals Co., Ltd, Shenzhen, Guangdong, China.
Wang JG; Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Pokaż więcej
Źródło :: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2023 Aug; Vol. 46 (8), pp. 2024-2032. Date of Electronic Publication: 2023 May 31.
Typ publikacji :: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
MeSH Terms :: Antihypertensive Agents*/adverse effects
Essential Hypertension*/drug therapy
Humans ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Double-Blind Method ; Drug Combinations ; Tetrazoles/adverse effects ; Treatment Outcome ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Nomogram-based risk assessment model for left ventricular hypertrophy in patients with essential hypertension: Incorporating clinical characteristics and biomarkers.
Autorzy :: Wang CC; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Liang LK; Yunkang school of medicine and health, Nanfang College, Guangzhou, China.
Luo SM; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Wang HC; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Wang XL; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Cheng YH; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Pan GM; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Peng JY; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Han SJ; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Wang X; Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Applicants with the same educational background for master's degree, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.; Pokaż więcej
Źródło :: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2024 Apr; Vol. 26 (4), pp. 363-373. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji :: Multicenter Study; Journal Article
MeSH Terms :: Hypertrophy, Left Ventricular*/diagnosis
Hypertrophy, Left Ventricular*/epidemiology
Hypertrophy, Left Ventricular*/etiology
Hypertension*/complications
Hypertension*/diagnosis
Hypertension*/epidemiology
Male ; Humans ; Female ; Retrospective Studies ; Nomograms ; Biomarkers ; Risk Assessment ; Essential Hypertension/complications ; Essential Hypertension/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Hypothalamic Corticotropin-Releasing Hormone Contributes to Hypertension in Spontaneously Hypertensive Rats.
Autorzy :: Zhang H; Department of Medicine, Center for Precision Medicine, School of Medicine, University of Missouri, Columbia, Missouri 65212.
Zhou JJ; Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Shao JY; Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Sheng ZF; Department of Medicine, Center for Precision Medicine, School of Medicine, University of Missouri, Columbia, Missouri 65212.
Wang J; Department of Medicine, Center for Precision Medicine, School of Medicine, University of Missouri, Columbia, Missouri 65212.
Zheng P; Department of Medicine, Center for Precision Medicine, School of Medicine, University of Missouri, Columbia, Missouri 65212.
Kang X; Department of Medicine, Center for Precision Medicine, School of Medicine, University of Missouri, Columbia, Missouri 65212.
Liu Z; Department of Medicine, Center for Precision Medicine, School of Medicine, University of Missouri, Columbia, Missouri 65212.
Cheng ZJ; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida 32827.
Kline DD; Department of Biomedical Sciences, Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65212.
Li DP; Department of Medicine, Center for Precision Medicine, School of Medicine, University of Missouri, Columbia, Missouri 65212 .; Pokaż więcej
Źródło :: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2023 Jun 14; Vol. 43 (24), pp. 4513-4524. Date of Electronic Publication: 2023 May 09.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Essential Hypertension*/metabolism
Hypertension*/metabolism
Receptors, N-Methyl-D-Aspartate*/metabolism
Animals ; Male ; Rats ; Adrenocorticotropic Hormone ; Corticotropin-Releasing Hormone/metabolism ; Paraventricular Hypothalamic Nucleus/metabolism ; Pituitary Hormone-Releasing Hormones/metabolism ; Pituitary Hormone-Releasing Hormones/pharmacology ; Rats, Inbred SHR ; Rats, Inbred WKY ; Sympathetic Nervous System/physiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Comparative Efficacy and Safety of Amlodipine and Losartan Potassium in Essential Hypertension in a Tertiary Hospital of Bangladesh.
Autorzy :: Shimu RN; Dr Rehana Naznin Shimu, Lecturer, Department of Pharmacology, Mymensingh Medical College (MMC), Mymensingh, Bangladesh; E-mail: .
Majumder S
Tarannum F
Chowdhury DP
Nahar A
Afrin A
Akter M
Nahar S
Jahan S
Hossain MA; Pokaż więcej
Źródło :: Mymensingh medical journal : MMJ [Mymensingh Med J] 2024 Apr; Vol. 33 (2), pp. 365-372.
Typ publikacji :: Observational Study; Journal Article
MeSH Terms :: Hypertension*/drug therapy
Mercury*/pharmacology
Mercury*/therapeutic use
Male ; Humans ; Female ; Losartan/therapeutic use ; Losartan/pharmacology ; Amlodipine/therapeutic use ; Amlodipine/pharmacology ; Bangladesh ; Tertiary Care Centers ; Antihypertensive Agents/therapeutic use ; Essential Hypertension/drug therapy ; Essential Hypertension/chemically induced ; Blood Pressure ; Treatment Outcome ; Double-Blind Method
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Clinical application of acupressure in patients with essential hypertension.
Autorzy :: Yan H; Traditional Chinese Medicine Department, Zigong First People's Hospital, Zigong, PR China.
Zhou X; Traditional Chinese Medicine Department, Zigong First People's Hospital, Zigong, PR China.
Gan G; Traditional Chinese Medicine Department, Zigong First People's Hospital, Zigong, PR China. Electronic address: .
Zhang J; Zigong Tourism Vocational High School, Zigong, PR China.; Pokaż więcej
Źródło :: Asian journal of surgery [Asian J Surg] 2024 Apr; Vol. 47 (4), pp. 1957-1958. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji :: Letter
MeSH Terms :: Acupressure*
Humans ; Essential Hypertension/therapy ; Patients
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: The efficacy of Tai Chi for essential hypertension: A systematic review and meta-analysis.
Autorzy :: Zhang P; Chongqing Metropolitan College of Science and Technology, Chongqing, China.
Zhang D; Chongqing Metropolitan College of Science and Technology, Chongqing, China.
Lu D; University of Illinois at Chicago, Chicago, Illinois, USA.; Pokaż więcej
Źródło :: International journal of nursing practice [Int J Nurs Pract] 2024 Apr; Vol. 30 (2), pp. e13211. Date of Electronic Publication: 2023 Oct 05.
Typ publikacji :: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms :: Tai Ji*/methods
Hypertension*/prevention & control
Adult ; Humans ; Middle Aged ; Nitric Oxide ; Essential Hypertension/therapy ; Blood Pressure
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Left ventricle hypertrophy and re-modeling in children with essential hypertension: does the race matter?
Autorzy :: Takajo D; Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, USA.
Przybycien TS; Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, USA.
Balakrishnan PL; Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, USA.
Natarajan G; Division of Neonatal & Perinatal Medicine, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, USA.
Singh GK; Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, USA.
Aggarwal S; Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, USA.; Pokaż więcej
Źródło :: Cardiology in the young [Cardiol Young] 2024 Apr; Vol. 34 (4), pp. 906-913. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji :: Journal Article
MeSH Terms :: Hypertrophy, Left Ventricular*/diagnostic imaging
Hypertrophy, Left Ventricular*/epidemiology
Hypertrophy, Left Ventricular*/complications
Hypertension*/complications
Hypertension*/epidemiology
Child ; Humans ; Heart Ventricles/diagnostic imaging ; Cross-Sectional Studies ; Essential Hypertension/complications ; Obesity/complications
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Gastroesophageal reflux disease increases the risk of essential hypertension: results from the Nationwide Readmission Database and Mendelian randomization analysis.
Autorzy :: Yao Z; Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.; Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; 'Chuangxin China' Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.
Zhao C; Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.; Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; 'Chuangxin China' Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.
Zhang Y; Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.; Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; 'Chuangxin China' Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.
Fan X; Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.; Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; 'Chuangxin China' Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.
Zhao D; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing 101149, China.
Gao L; Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.; Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; 'Chuangxin China' Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong 250021, China.; Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.; Pokaż więcej
Źródło :: Postgraduate medical journal [Postgrad Med J] 2024 Mar 18; Vol. 100 (1182), pp. 242-251.
Typ publikacji :: Observational Study; Journal Article
MeSH Terms :: Hypertension*/epidemiology
Hypertension*/genetics
Gastroesophageal Reflux*/epidemiology
Gastroesophageal Reflux*/genetics
Humans ; Mendelian Randomization Analysis ; Genome-Wide Association Study ; Patient Readmission ; Essential Hypertension
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Causal Relationship Between Branched-Chain Amino Acids and Hypertension: A Mendelian Randomization Study.
Autorzy :: Cai S; School of Public Health, Shanghai Jiao Tong University School of Medicine Shanghai China.
Fu Y; School of Public Health, Shanghai Jiao Tong University School of Medicine Shanghai China.
Chen J; School of Public Health, Shanghai Jiao Tong University School of Medicine Shanghai China.
Tian M; Department of Clinical Nutrition, Shanghai Deji Hospital Affiliated to Qingdao University Shanghai China.
Li X; School of Public Health, Shanghai Jiao Tong University School of Medicine Shanghai China.; Pokaż więcej
Źródło :: Journal of the American Heart Association [J Am Heart Assoc] 2024 Mar 05; Vol. 13 (5), pp. e032084. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji :: Meta-Analysis; Journal Article
MeSH Terms :: Amino Acids, Branched-Chain*/metabolism
Hypertension*/epidemiology
Hypertension*/genetics
Hypertension*/chemically induced
Humans ; Isoleucine/genetics ; Leucine ; Mendelian Randomization Analysis ; Valine ; Essential Hypertension ; Genome-Wide Association Study
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Effect of Accessory Renal Arteries on Essential Hypertension and Related Mechanisms.
Autorzy :: Wu F; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Yuan X; Department of Clinical Laboratory First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Sun K; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Zhang Y; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Zhu L; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Bai C; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Cheng Y; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Lu Y; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Jiang Y; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.
Song W; Department of Cardiology First Affiliated Hospital of Dalian Medical University Dalian Liaoning China.; Pokaż więcej
Źródło :: Journal of the American Heart Association [J Am Heart Assoc] 2024 Feb 20; Vol. 13 (4), pp. e030427. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji :: Journal Article
MeSH Terms :: Hypertension*
Humans ; Aldosterone ; Case-Control Studies ; Renal Artery ; Blood Pressure Monitoring, Ambulatory ; Blood Pressure/physiology ; Essential Hypertension/diagnosis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Evening versus morning dosing regimen drug therapy for hypertension.
Autorzy :: Wu C; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
Zhao P; Medical Library, Sichuan University, Chengdu, China.
Xu P; Medical Library, Sichuan University, Chengdu, China.
Wan C; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Singh S; Pharmacology Department, All India Institute of Medical Sciences, Jodhpur, India.
Varthya SB; Pharmacology Department, All India Institute of Medical Sciences, Jodhpur, India.
Luo SH; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.; Pokaż więcej
Źródło :: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Feb 14; Vol. 2. Cochrane AN: CD004184. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji :: Systematic Review; Meta-Analysis; Journal Article; Review
MeSH Terms :: Antihypertensive Agents*/adverse effects
Hypertension*
Humans ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Essential Hypertension/chemically induced ; Essential Hypertension/complications ; Essential Hypertension/drug therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Relationship Between Atherogenic Index of Plasma and Serum Uric Acid in Patients With Untreated Essential Hypertension in China: A Cross-Sectional Study.
Autorzy :: Ma X; Department of Health Management Center and Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Zhang X; Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Yang Y; Department of Health Management Center and Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Jiang L; Department of Health Management Center and Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Huang Z; Department of Health Management Center and Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.; Pokaż więcej
Źródło :: Angiology [Angiology] 2024 Feb; Vol. 75 (2), pp. 148-155. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji :: Journal Article
MeSH Terms :: Diabetes Mellitus*
Hyperuricemia*/diagnosis
Hyperuricemia*/epidemiology
Male ; Middle Aged ; Female ; Humans ; Uric Acid ; Cross-Sectional Studies ; Risk Factors ; Essential Hypertension ; China/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Expression of soluble ST2 in patients with essential hypertension and its relationship with left ventricular hypertrophy.
Autorzy :: Wei P; Department of Cardiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
Liu L; Department of Cardiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
Wang X; Department of Cardiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
Zong B; Department of Cardiology, The Xuzhou School of Clinical Medicine, Nanjing Medical University, Xuzhou, Jiangsu, China.
Liu X; Experimental Center, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
Zhang M; Laboratory of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
Fu Q; Department of Cardiology, The Xuzhou School of Clinical Medicine, Nanjing Medical University, Xuzhou, Jiangsu, China.
Wang L; Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, Jiangsu, China.
Cao B; Department of Cardiology, Yantai Affiliated Hospital of Binzhou Medical University, No. 717 Jinbu Road, Mouping District, Yantai, 264100, Shandong, China.; Pokaż więcej
Źródło :: ESC heart failure [ESC Heart Fail] 2023 Feb; Vol. 10 (1), pp. 303-310. Date of Electronic Publication: 2022 Oct 09.
Typ publikacji :: Journal Article
MeSH Terms :: Essential Hypertension*/complications
Hypertrophy, Left Ventricular*
Interleukin-1 Receptor-Like 1 Protein*/blood
Humans ; Biomarkers
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Evaluation of the efficacy of hydro-alcoholic extract of Evolvulus alsinoides L. for the treatment of primary hypertension - A randomized controlled trial.
Autorzy :: Binth Siraj M; Dept. of Pathology, Hayat Unani Medical College and Research Centre, Lucknow, 226101, Uttar Pradesh, India. Electronic address: .
Khan AA; Dept. of Medicine (Unani), School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, 110062, India. Electronic address: asim_.
Jahangir U; Dept. of Amraz-e-Jild wa Tazeeniyat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, 110062, India. Electronic address: umar_.
Hashimi A; Research Associate, Central Research Unit (Unani), Meerut, Uttar Pradesh, 250001, India. Electronic address: .
Ahmad Y; Dept. of Medicine (Unani), School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, 110062, India. Electronic address: .
Husain N; Research Officer, Regional Research Instiute of Unani Medicine, Silchar, Assam, 788014, India. Electronic address: .; Pokaż więcej
Źródło :: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Apr 06; Vol. 323, pp. 117661. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji :: Randomized Controlled Trial; Journal Article
MeSH Terms :: Hypertension*/drug therapy
Convolvulaceae*
Humans ; Ramipril/therapeutic use ; Ramipril/pharmacology ; C-Reactive Protein ; Interleukin-6 ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/pharmacology ; Blood Pressure ; Headache/drug therapy ; Essential Hypertension/drug therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Telmisartan-Induced Myotoxicity in Patients with Essential Hypertension.
Autorzy :: Kara SC; Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Canpolat U; Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.; Pokaż więcej
Transliterated Title :: Esansiyel Hipertansiyonlu Hastalarda Telmisartan Kaynaklı Miyotoksisite.
Źródło :: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir [Turk Kardiyol Dern Ars] 2024 Apr; Vol. 52 (3), pp. 217-219.
Typ publikacji :: Case Reports
MeSH Terms :: Myotoxicity*
Drug-Related Side Effects and Adverse Reactions*
Humans ; Telmisartan/adverse effects ; Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors ; Essential Hypertension/drug therapy
: Raport

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
Autorzy :: Zhang W; Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.; The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Li X; Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.
Li W; Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.
Zhang Y; Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.
Cai J; Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.
Feng S; Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.
Sun Z; Department of Laboratory Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China.; The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.; Pokaż więcej
Źródło :: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2024 Apr; Vol. 26 (4), pp. 416-424. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji :: Journal Article
MeSH Terms :: Pheochromocytoma*/complications
Pheochromocytoma*/diagnosis
Hypertension*/diagnosis
Paraganglioma*/complications
Paraganglioma*/diagnosis
Adrenal Gland Neoplasms*/complications
Adrenal Gland Neoplasms*/diagnosis
Mandelic Acids*
Humans ; Catecholamines ; Metanephrine ; Normetanephrine ; Dopamine ; Chromatography, Liquid/methods ; Liquid Chromatography-Mass Spectrometry ; Tandem Mass Spectrometry/methods ; Norepinephrine ; Essential Hypertension/diagnosis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: ATP2B1 gene polymorphisms associated with resistant hypertension in the Japanese population.
Autorzy :: Kobayashi Y; Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University, Yokohama, Japan.; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yatsu K; Minna no Naika Clinic Ningyocho-Suitengu, Tokyo, Japan.
Haruna A; Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Kawano R; Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Ozawa M; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
Haze T; Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University, Yokohama, Japan.; Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Komiya S; Department of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
Suzuki S; Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Ohki Y; Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Fujiwara A; Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Saka S; Department of Nephrology and Hypertension, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
Hirawa N; Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.
Toya Y; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Tamura K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Pokaż więcej
Źródło :: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2024 Apr; Vol. 26 (4), pp. 355-362. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji :: Journal Article
MeSH Terms :: Hypertension*/drug therapy
Hypertension*/epidemiology
Hypertension*/genetics
Humans ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/pharmacology ; Japan/epidemiology ; Essential Hypertension/drug therapy ; Blood Pressure/genetics ; Polymorphism, Single Nucleotide ; Plasma Membrane Calcium-Transporting ATPases/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: THE RISKS OF FIRST ONSET PRIMARY HYPERTENSION DIAGNOSIS IN THERMAL-INJURED PATIENTS.
Autorzy :: Efejuku TA; School of Medicine.
Wolf SE; Department of Surgery.
Song J; Department of Surgery.
Golovko G; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas.
El Ayadi A; Department of Surgery.; Pokaż więcej
Źródło :: Shock (Augusta, Ga.) [Shock] 2024 Apr 01; Vol. 61 (4), pp. 541-548. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji :: Journal Article
MeSH Terms :: Burns*
Hypertension*/complications
Acute Kidney Injury*/diagnosis
Acute Kidney Injury*/etiology
Hyperglycemia*/complications
Heart Failure*
Male ; Humans ; Female ; Retrospective Studies ; Essential Hypertension/complications
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Evaluation of endothelial dysfunction in hypertensive children and adolescents.
Autorzy :: Doğan K; Department of Pediatric Nephrology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey. .
Başar EZ; Department of Pediatric Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Aytaç MB; Department of Pediatric Nephrology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Şahin N; Department of Pediatric Rheumatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Bayrak YE; Department of Pediatric Rheumatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Bek K; Department of Pediatric Nephrology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Güngör HS; Department of Pediatric Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Sönmez HE; Department of Pediatric Rheumatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Babaoğlu K; Department of Pediatric Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.; Pokaż więcej
Źródło :: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 Apr; Vol. 39 (4), pp. 1193-1199. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji :: Journal Article
MeSH Terms :: Hypertension*
Atherosclerosis*/complications
Male ; Female ; Child ; Humans ; Adolescent ; Carotid Intima-Media Thickness ; Cross-Sectional Studies ; Essential Hypertension ; Endothelium, Vascular ; Vasodilation
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaBiblioteka UWSB Merito Chorzów

Wyszukujesz frazę ""ESSENTIAL hypertension"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Dostawca treści

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Hasło geograficzne

Kategoria

Rok publikacji